Stockreport

Pfizer – Roivant tie-up generates positive mid-stage data for lead asset [Seeking Alpha]

Roivant Sciences Ltd.  (ROIV) 
PDF Pfizer ( PFE ) and Roivant Sciences ( ROIV ), announced positive mid-stage trial results for its lead asset, brepocitinib, in cutaneous sarcoidosis, a skin disorder with [Read more]